Activity of the type I signal peptidase inhibitor MD3 against multidrug-resistant Gram-negative bacteria alone and in combination with colistin

Activity of colistin in combination with tigecycline or rifampicin against multidrug-resistant Stenotrophomonas maltophilia

(2014) J. W. Betts et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Synergistic Activity of Colistin and Rifampin Combination against Multidrug-Resistant Acinetobacter baumannii in anIn VitroPharmacokinetic/Pharmacodynamic Model

(2013) Hee Ji Lee et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In vitro activity of the novel monosulfactam BAL30072 alone and in combination with meropenem versus a diverse collection of important Gram-negative pathogens

(2013) Michael Hornsey et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Differential Potentiation of the Virulence of the Pseudomonas aeruginosa Cystic Fibrosis Liverpool Epidemic Strain by Oral Commensal Streptococci

(2013) Robert A. Whiley et al.   JOURNAL OF INFECTIOUS DISEASES

In VitroActivity of Telavancin in Combination with Colistin versus Gram-Negative Bacterial Pathogens

(2012) Michael Hornsey et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Pseudomonas aeruginosa Possesses Two Putative Type I Signal Peptidases, LepB and PA1303, Each with Distinct Roles in Physiology and Virulence

(2012) R. D. Waite et al.   JOURNAL OF BACTERIOLOGY

Inhibition of the Sole Type I Signal Peptidase of Mycobacterium tuberculosis Is Bactericidal under Replicating and Nonreplicating Conditions

(2012) J. Ollinger et al.   JOURNAL OF BACTERIOLOGY

In vitro activity of teicoplanin combined with colistin versus multidrug-resistant strains of Acinetobacter baumannii

(2011) D. W. Wareham et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Initial Efforts toward the Optimization of Arylomycins for Antibiotic Activity

(2011) Tucker C. Roberts et al.   JOURNAL OF MEDICINAL CHEMISTRY

Signal peptidase I: Cleaving the way to mature proteins

(2011) Sarah M. Auclair et al.   PROTEIN SCIENCE

Potent Synergy and Sustained Bactericidal Activity of a Vancomycin-Colistin Combination versus Multidrug-Resistant Strains of Acinetobacter baumannii

(2010) N. C. Gordon et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Broad-Spectrum Antibiotic Activity of the Arylomycin Natural Products Is Masked by Natural Target Mutations

(2010) Peter A. Smith et al.   CHEMISTRY & BIOLOGY

AdeABC-mediated efflux and tigecycline MICs for epidemic clones of Acinetobacter baumannii

(2010) M. Hornsey et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Proteolytic processing of Escherichia coli twin-arginine signal peptides by LepB

(2009) Iris Lüke et al.   ARCHIVES OF MICROBIOLOGY

Crystallographic Analysis of Bacterial Signal Peptidase in Ternary Complex with Arylomycin A2and a β-Sultam Inhibitor

(2009) Chuanyun Luo et al.   BIOCHEMISTRY

Enzymatic investigation of theStaphylococcus aureustype I signal peptidase SpsB - implications for the search for novel antibiotics

(2009) Smitha Rao et al.   FEBS Journal

Clonal Dissemination of Klebsiella pneumoniae Carbapenemase KPC-3 in Long Beach, California

(2009) J. Le et al.   JOURNAL OF CLINICAL MICROBIOLOGY

An easy and fast method for the evaluation of Staphylococcus epidermidis type I signal peptidase inhibitors

(2009) Katrijn Bockstael et al.   JOURNAL OF MICROBIOLOGICAL METHODS

PBAD-Based Shuttle Vectors for Functional Analysis of Toxic and Highly Regulated Genes in Pseudomonas and Burkholderia spp. and Other Bacteria

(2008) D. Qiu et al.   APPLIED AND ENVIRONMENTAL MICROBIOLOGY

Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America

(2008) Helen W. Boucher et al.   CLINICAL INFECTIOUS DISEASES